{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T15:31:41Z","timestamp":1771342301543,"version":"3.50.1"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background and objective<\/jats:title>\n                  <jats:p>The exact underlying mechanism for the differential clinical profiles of symptomatic and asymptomatic primary hyperparathyroidism (PHPT) patients has not been fully elucidated, and efforts to define the molecular mechanisms underlying the phenotypic heterogeneity of PHPT have been limited. The aim of this study was to explore the underlying molecular mechanisms involved in the pathogenesis of symptomatic and asymptomatic sporadic PHPT in Asian Indians.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A prospective cohort study was conducted at a tertiary care hospital in North India. PHPT patients who underwent parathyroidectomy were included. The main outcome was the comparison of vitamin D receptor (VDR), calcium-sensing receptor (CaSR), cyclin D 1 (CD1), and parathyroid hormone (PTH) mRNA levels between symptomatic and asymptomatic PHPT patients and controls determined via quantitative real-time polymerase chain reaction (qRT-PCR).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Forty-two PHPT patients were studied. The mean (SD) age was 49.7 (12.8) years. Twenty patients were asymptomatic. The median PTH levels were significantly greater in the symptomatic group than in the asymptomatic group (878 vs 653\u2005pg\/mL). CaSR and VDR mRNAs were significantly lower in both symptomatic and asymptomatic patients than in controls. CD1 and PTH mRNAs were significantly increased in symptomatic patients, but not in asymptomatic PHPT patients compared with controls. Symptomatic PHPT patients had significantly greater CD1 mRNA expression and reduced CaSR expression than asymptomatic patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Symptomatic PHPT patients had significantly greater CD1 mRNA expression and lower CaSR expression than asymptomatic patients, underscoring the importance of the molecular mechanisms underlying the phenotypic heterogeneity of PHPT.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ejendo\/lvae122","type":"journal-article","created":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T18:23:33Z","timestamp":1727807013000},"page":"457-462","source":"Crossref","is-referenced-by-count":2,"title":["mRNA expression of vitamin D receptor, calcium-sensing receptor, cyclin D1, and PTH in symptomatic and asymptomatic primary hyperparathyroidism"],"prefix":"10.1093","volume":"191","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5642-2291","authenticated-orcid":false,"given":"Parjeet","family":"Kaur","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Diabetes, Medanta \u2014 The Medicity , Gurugram, 122001 Haryana ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dwijraj","family":"Hegde","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes, Medanta \u2014 The Medicity , Gurugram, 122001 Haryana ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyanka","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Postgraduate Institute of Medical Education and Research (PGIMER) , 160012 Chandigarh ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dheeraj","family":"Gautam","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Medanta \u2014 The Medicity , Gurugram, 122001 Haryana ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepak","family":"Sarin","sequence":"additional","affiliation":[{"name":"Department of Head and Neck Surgery, Medanta \u2014 The Medicity , Gurugram, 122001 Haryana ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay","family":"Bhadada","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Postgraduate Institute of Medical Education and Research (PGIMER) , 160012 Chandigarh ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ambrish","family":"Mithal","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes, Medanta \u2014 The Medicity , Gurugram, 122001 Haryana ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,10,1]]},"reference":[{"issue":"1","key":"2024102913464269100_lvae122-B1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jocd.2012.11.005","article-title":"Asymptomatic primary hyperparathyroidism","volume":"16","author":"Silverberg","year":"2013","journal-title":"J Clin Densitom"},{"issue":"2","key":"2024102913464269100_lvae122-B2","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s00774-017-0833-8","article-title":"Primary hyperparathyroidism: insights from the Indian PHPT registry","volume":"36","author":"Bhadada","year":"2018","journal-title":"J Bone Miner Metab"},{"key":"2024102913464269100_lvae122-B3","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/B978-012098651-4\/50024-9","volume-title":"Read the Parathyroids","author":"Mithal","year":"2001","edition":"2nd ed"},{"key":"2024102913464269100_lvae122-B4","first-page":"694","article-title":"Changes in clinical & biochemical presentations of primary hyperparathyroidism in India over a period of 20 years","volume":"139","author":"Shah","year":"2014","journal-title":"Indian J Med Res"},{"issue":"2","key":"2024102913464269100_lvae122-B5","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s00774-020-01142-w","article-title":"Progressive rise in the prevalence of asymptomatic primary hyperparathyroidism in India: data from PHPT registry","volume":"39","author":"Arya","year":"2021","journal-title":"J Bone Miner Metab"},{"issue":"6","key":"2024102913464269100_lvae122-B6","doi-asserted-by":"publisher","first-page":"581","DOI":"10.4158\/EP14447.OR","article-title":"Asymptomatic primary hyperparathyroidism exists in north India: retrospective data from 2 tertiary care centers","volume":"21","author":"Mithal","year":"2015","journal-title":"Endocr Pract"},{"issue":"5","key":"2024102913464269100_lvae122-B7","doi-asserted-by":"publisher","first-page":"625","DOI":"10.4103\/2230-8210.190540","article-title":"Impact of preoperative imaging on surgical approach for primary hyperparathyroidism: data from single institution in India","volume":"20","author":"Kaur","year":"2016","journal-title":"Indian J Endocrinol Metab"},{"issue":"2","key":"2024102913464269100_lvae122-B8","doi-asserted-by":"publisher","first-page":"R53","DOI":"10.1530\/ERC-18-0304","article-title":"Molecular genetic insights into sporadic primary hyperparathyroidism","volume":"26","author":"Brewer","year":"2019","journal-title":"Endocr Relat Cancer"},{"issue":"5","key":"2024102913464269100_lvae122-B9","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1210\/jcem.85.5.6607","article-title":"Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidism","volume":"85","author":"Carling","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2024102913464269100_lvae122-B10","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1046\/j.1365-2265.2000.01081.x","article-title":"Reduced vitamin D receptor expression in parathyroid adenomas: implications for pathogenesis","volume":"53","author":"Rao","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2024102913464269100_lvae122-B11","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1530\/eje.0.1480403","article-title":"Decrease in vitamin D receptor and calcium-sensing receptor in highly proliferative parathyroid adenomas","volume":"148","author":"Yano","year":"2003","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"2024102913464269100_lvae122-B12","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1210\/jcem.82.10.4300","article-title":"Tumor-specific decreased expression of calcium sensing receptor messenger ribonucleic acid in sporadic primary hyperparathyroidism","volume":"82","author":"Farnebo","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2024102913464269100_lvae122-B13","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/ki.1997.41","article-title":"Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism","volume":"51","author":"Gogusev","year":"1997","journal-title":"Kidney Int"},{"issue":"3","key":"2024102913464269100_lvae122-B14","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1530\/eje.1.01864","article-title":"Distinction in gene expression profiles demonstrated in parathyroid adenomas by high-density oligoarray technology","volume":"152","author":"Forsberg","year":"2005","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2024102913464269100_lvae122-B15","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1210\/jcem.81.5.8626826","article-title":"Cyclin D1\/PRAD1 expression in parathyroid adenomas: an immunohistochemical study","volume":"81","author":"Hsi","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2024102913464269100_lvae122-B16","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1046\/j.1523-1755.1999.00396.x","article-title":"Expression of PRAD1\/cyclin D1, retinoblastoma gene products, and Ki67 in parathyroid hyperplasia caused by chronic renal failure versus primary adenoma","volume":"55","author":"Tominaga","year":"1999","journal-title":"Kidney Int"},{"issue":"9","key":"2024102913464269100_lvae122-B17","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/ncpendmet0265","article-title":"The diagnosis and management of asymptomatic primary hyperparathyroidism","volume":"2","author":"Silverberg","year":"2006","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"10","key":"2024102913464269100_lvae122-B18","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1210\/jc.2014-1413","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the fourth international workshop","volume":"99","author":"Bilezikian","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2024102913464269100_lvae122-B19","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1530\/EJE-13-0085","article-title":"Simultaneous expression analysis of vitamin D receptor, calcium-sensing receptor, cyclin D1, and PTH in symptomatic primary hyperparathyroidism in Asian Indians","volume":"169","author":"Varshney","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"2024102913464269100_lvae122-B20","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1210\/clinem\/dgaa419","article-title":"Reduced calcium sensing receptor (CaSR) expression is epigenetically deregulated in parathyroid adenomas","volume":"105","author":"Singh","year":"2020","journal-title":"J Clin Endocrinol Metab."},{"key":"2024102913464269100_lvae122-B21","first-page":"412","article-title":"Expression of cyclin D1 in parathyroid carcinomas, adenomas, and hyperplasias: a paraffin immunohistochemical study","volume":"12","author":"Vasef","year":"1999","journal-title":"Mod Pathol"},{"issue":"9","key":"2024102913464269100_lvae122-B22","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1172\/JCI10523","article-title":"Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice","volume":"107","author":"Imanishi","year":"2001","journal-title":"J Clin Invest"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejendo\/advance-article-pdf\/doi\/10.1093\/ejendo\/lvae122\/59486532\/lvae122.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/191\/4\/457\/60091969\/lvae122.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/191\/4\/457\/60091969\/lvae122.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T13:46:56Z","timestamp":1730209616000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/191\/4\/457\/7802709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,30]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,9,30]]}},"URL":"https:\/\/doi.org\/10.1093\/ejendo\/lvae122","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,10]]},"published":{"date-parts":[[2024,9,30]]}}}